The trademark application ELATIVE was filed by GENFIT, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on February 10, 2021, and it was registered by office on May 20, 2021 without any oppositions.
The application was filed in French (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on April 6, 2022.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Chemical preparations for medical or pharmaceutical purposes
Biological preparations for medical and pharmaceutical purposes
Diagnostic preparations for medical purposes
Diagnostic reagents for medical use.
The mark was filed in class 42 with following description of goods:
Scientific research for medical purposes
Pharmaceutical research and development
Conducting clinical trials for pharmaceutical products, In particular conducting clinical trials to determine the efficacy and safety of elafibranor
Conducting clinical trials to determine the efficacy and safety of pharmaceutical preparations in the treatment of primary biliary cholangitis (PBC)
Conducting scientific studies and analyses
Providing of information, results and data relating to scientific or medical research and development of pharmaceutical preparations, in particular via a database able to be consulted online
Clinical trials
Biological and pharmaceutical development and research services for others